Literature DB >> 19558307

Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved women.

Alecia Malin Fair1, Debra Wujcik, Jin-Mann S Lin, Ana Grau, Veronica Wilson, Victoria Champion, Wei Zheng, Kathleen M Egan.   

Abstract

BACKGROUND: The relationship between obesity and screening mammography adherence has been examined previously, yet few studies have investigated obesity as a potential mediator of timely follow-up of abnormal (Breast Imaging Reporting and Data System [BIRADS-0]) mammography results in minority and medically underserved patients.
METHODS: We conducted a retrospective cohort study of 35 women who did not return for follow-up >6 months from index abnormal mammography and 41 who returned for follow-up < or =6 months in Nashville, Tennessee. Patients with a BIRADS-0 mammography event in 2003-2004 were identified by chart review. Breast cancer risk factors were collected by telephone interview. Multivariate logistic regression was performed on selected factors with return for diagnostic follow-up.
RESULTS: Obesity and gynecological history were significant predictors of abnormal mammography resolution. A significantly higher frequency of obese women delayed return for mammography resolution compared with nonobese women (64.7% vs. 35.3%). A greater number of hysterectomized women returned for diagnostic follow-up compared with their counterparts without a hysterectomy (77.8% vs. 22.2%). Obese patients were more likely to delay follow-up >6 months (adjusted OR 4.09, p = 0.02). Conversely, hysterectomized women were significantly more likely to return for timely mammography follow-up < or =6 months (adjusted OR 7.95, p = 0.007).
CONCLUSIONS: Study results suggest that weight status and gynecological history influence patients' decisions to participate in mammography follow-up studies. Strategies are necessary to reduce weight-related barriers to mammography follow-up in the healthcare system including provider training related to mammography screening of obese women.

Entities:  

Mesh:

Year:  2009        PMID: 19558307      PMCID: PMC2851132          DOI: 10.1089/jwh.2008.0791

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  45 in total

Review 1.  Influence of delay on survival in patients with breast cancer: a systematic review.

Authors:  M A Richards; A M Westcombe; S B Love; P Littlejohns; A J Ramirez
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

2.  Body weight and health care among women in the general population.

Authors:  K R Fontaine; M S Faith; D B Allison; L J Cheskin
Journal:  Arch Fam Med       Date:  1998 Jul-Aug

3.  Cigarette smoking, alcohol consumption, and screening mammography among women ages 50 and older.

Authors:  L Fredman; M Sexton; Y Cui; M Althuis; L Wehren; P Hornbeck; N Kanarek
Journal:  Prev Med       Date:  1999-04       Impact factor: 4.018

4.  Prevalences and correlates of ethnic harassment in the U.S. Women Physicians' Health Study.

Authors:  G Corbie-Smith; E Frank; H W Nickens; L Elon
Journal:  Acad Med       Date:  1999-06       Impact factor: 6.893

5.  Participation rates in a case-control study: the impact of age, race, and race of interviewer.

Authors:  P G Moorman; B Newman; R C Millikan; C K Tse; D P Sandler
Journal:  Ann Epidemiol       Date:  1999-04       Impact factor: 3.797

6.  Increasing breast and cervical cancer screening in low-income women.

Authors:  K L Margolis; N Lurie; P G McGovern; M Tyrrell; J S Slater
Journal:  J Gen Intern Med       Date:  1998-08       Impact factor: 5.128

7.  Perceptions of cancer fatalism among African Americans: the influence of education, income, and cancer knowledge.

Authors:  B D Powe
Journal:  J Natl Black Nurses Assoc       Date:  1994 Fall-Winter

8.  Cancer fatalism among elderly Caucasians and African Americans.

Authors:  B D Powe
Journal:  Oncol Nurs Forum       Date:  1995-10       Impact factor: 2.172

9.  Validity of self-reported mammography in low-income African-American women.

Authors:  V L Champion; U Menon; D H McQuillen; C Scott
Journal:  Am J Prev Med       Date:  1998-02       Impact factor: 5.043

10.  Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk?

Authors:  Steven S Coughlin; Robert J Uhler; H Irene Hall; Peter A Briss
Journal:  Prev Chronic Dis       Date:  2003-12-15       Impact factor: 2.830

View more
  5 in total

1.  Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women.

Authors:  Alecia Malin Fair; Debra Wujcik; Jin-Mann Sally Lin; Wei Zheng; Kathleen M Egan; Ana M Grau; Victoria L Champion; Kenneth A Wallston
Journal:  J Health Care Poor Underserved       Date:  2010-02

2.  Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.

Authors:  Nicolien T van Ravesteyn; Clyde B Schechter; Aimee M Near; Eveline A M Heijnsdijk; Michael A Stoto; Gerrit Draisma; Harry J de Koning; Jeanne S Mandelblatt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-30       Impact factor: 4.254

3.  Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography.

Authors:  Danielle D Durham; Whitney R Robinson; Sheila S Lee; Stephanie B Wheeler; Katherine E Reeder-Hayes; J Michael Bowling; Andrew F Olshan; Louise M Henderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11       Impact factor: 4.254

4.  Improving healthcare empowerment through breast cancer patient navigation: a mixed methods evaluation in a safety-net setting.

Authors:  Guzyal Gabitova; Nancy J Burke
Journal:  BMC Health Serv Res       Date:  2014-09-19       Impact factor: 2.655

5.  Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics.

Authors:  Cindy K Blair; Charles L Wiggins; Andrea M Nibbe; Curt B Storlie; Eric R Prossnitz; Melanie Royce; Lesley C Lomo; Deirdre A Hill
Journal:  NPJ Breast Cancer       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.